These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 23581910)
41. The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging. Bretsky P; Guralnik JM; Launer L; Albert M; Seeman TE; Neurology; 2003 Apr; 60(7):1077-81. PubMed ID: 12682309 [TBL] [Abstract][Full Text] [Related]
43. Apolipoprotein E genotype and mortality: findings from the Cache County Study. Hayden KM; Zandi PP; Lyketsos CG; Tschanz JT; Norton MC; Khachaturian AS; Pieper CF; Welsh-Bohmer KA; Breitner JC; J Am Geriatr Soc; 2005 Jun; 53(6):935-42. PubMed ID: 15935014 [TBL] [Abstract][Full Text] [Related]
44. Cognitive Activities, Lifestyle Factors, and Risk of Cognitive Impairment, with an Analysis of the Apolipoprotein Epsilon 4 Genotype. Sun Y; Wang Z; Sun S; Cui L; Zhu X; Ho SY; Qi S Gerontology; 2023; 69(9):1137-1146. PubMed ID: 37276850 [TBL] [Abstract][Full Text] [Related]
45. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia. McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545 [TBL] [Abstract][Full Text] [Related]
46. Apolipoprotein E Genotype Modifies the Association Between Cardiac Output and Cognition in Older Adults. Bown CW; Liu D; Osborn KE; Gupta DK; Mendes LA; Pechman KR; Hohman TJ; Wang TJ; Gifford KA; Jefferson AL J Am Heart Assoc; 2019 Aug; 8(15):e011146. PubMed ID: 31364446 [TBL] [Abstract][Full Text] [Related]
47. Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength. Batterham PJ; Bunce D; Cherbuin N; Christensen H Am J Geriatr Psychiatry; 2013 Oct; 21(10):1010-9. PubMed ID: 23567378 [TBL] [Abstract][Full Text] [Related]
48. The apolipoprotein E genotype predicts longitudinal transitions to mild cognitive impairment but not to Alzheimer's dementia: findings from a nationally representative study. Brainerd CJ; Reyna VF; Petersen RC; Smith GE; Kenney AE; Gross CJ; Taub ES; Plassman BL; Fisher GG Neuropsychology; 2013 Jan; 27(1):86-94. PubMed ID: 23356599 [TBL] [Abstract][Full Text] [Related]
49. Apolipoprotein E ε4 Modifies the Effect of Possible Anticholinergic Drugs on Incident Dementia: The Shanghai Aging Study. Chi D; Wu W; Zhao Q; Xiao Z; Luo J; Wang B; Ding D J Am Med Dir Assoc; 2023 Apr; 24(4):526-532. PubMed ID: 36842452 [TBL] [Abstract][Full Text] [Related]
50. Is ApoE epsilon4 associated with cognitive functioning in African Americans diagnosed with Alzheimer Disease? An exploratory study. Mount DL; Ashley AV; Lah JJ; Levey AI; Goldstein FC South Med J; 2009 Sep; 102(9):890-3. PubMed ID: 19668025 [TBL] [Abstract][Full Text] [Related]
51. Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease. Lim YY; Kalinowski P; Pietrzak RH; Laws SM; Burnham SC; Ames D; Villemagne VL; Fowler CJ; Rainey-Smith SR; Martins RN; Rowe CC; Masters CL; Maruff PT JAMA Neurol; 2018 Apr; 75(4):488-494. PubMed ID: 29356823 [TBL] [Abstract][Full Text] [Related]
52. APOE ε4 increases the risk of progression from amnestic mild cognitive impairment to Alzheimer's disease among ethnic Chinese in Taiwan. Wang PN; Hong CJ; Lin KN; Liu HC; Chen WT J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):165-9. PubMed ID: 20660919 [TBL] [Abstract][Full Text] [Related]
53. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway. Sando SB; Melquist S; Cannon A; Hutton ML; Sletvold O; Saltvedt I; White LR; Lydersen S; Aasly JO BMC Neurol; 2008 Apr; 8():9. PubMed ID: 18416843 [TBL] [Abstract][Full Text] [Related]
54. Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Bennett DA; Wilson RS; Schneider JA; Evans DA; Aggarwal NT; Arnold SE; Cochran EJ; Berry-Kravis E; Bienias JL Neurology; 2003 Jan; 60(2):246-52. PubMed ID: 12552039 [TBL] [Abstract][Full Text] [Related]
55. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study. Foster JK; Albrecht MA; Savage G; Lautenschlager NT; Ellis KA; Maruff P; Szoeke C; Taddei K; Martins R; Masters CL; Ames D; Brain; 2013 Jul; 136(Pt 7):2201-16. PubMed ID: 23737466 [TBL] [Abstract][Full Text] [Related]
56. Apolipoprotein e genotype, cortisol, and cognitive function in community-dwelling older adults. Lee BK; Glass TA; Wand GS; McAtee MJ; Bandeen-Roche K; Bolla KI; Schwartz BS Am J Psychiatry; 2008 Nov; 165(11):1456-64. PubMed ID: 18593777 [TBL] [Abstract][Full Text] [Related]
58. Cognitive impairment in Alzheimer's disease is modified by APOE genotype. van der Vlies AE; Pijnenburg YA; Koene T; Klein M; Kok A; Scheltens P; van der Flier WM Dement Geriatr Cogn Disord; 2007; 24(2):98-103. PubMed ID: 17596691 [TBL] [Abstract][Full Text] [Related]
59. Cognitive resilience among APOE ε4 carriers in the oldest old. Hayden KM; Gaussoin SA; Hunter JC; Manson JE; Sachs BC; Shadyab AH; Tindle HA; Mossavar-Rahmani Y; Mozhui K; Snively BM; Rapp SR; Resnick SM Int J Geriatr Psychiatry; 2019 Dec; 34(12):1833-1844. PubMed ID: 31418472 [TBL] [Abstract][Full Text] [Related]
60. APOE ε4 allele is associated with worse performance in memory dimensions of the mini-mental state examination: the Bambuí Cohort Study of Aging. Quintino-Santos S; Diniz BS; Firmo JO; Moriguchi EH; Lima-Costa MF; Castro-Costa E Int J Geriatr Psychiatry; 2015 Jun; 30(6):573-9. PubMed ID: 25132317 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]